Nurix Therapeutics (NRIX) EPS (Basic) (2019 - 2026)
Nurix Therapeutics (NRIX) posted quarterly EPS (Basic) of -$0.81 for Q2 2026, down 55.55% year-over-year from -$1.81 in Q2 2025, and down 0.88% quarter-over-quarter from -$0.8 in Q1 2026.
Powered by 
Analysis
Nurix Therapeutics (NRIX) EPS (Basic) (2019 - 2026) Analysis & Trends
Nurix Therapeutics (NRIX) has reported EPS (Basic) for 8 consecutive years, with -$0.81 the latest figure, recorded in Q2 2026.
- In Q2 2026, EPS (Basic) fell 55.55% year-over-year to -$0.81; the TTM figure through May 2026 stood at -$3.08 (down 24.61% YoY), while the FY2025 annual figure was -$3.05, down 5.81% from the prior year.
- EPS (Basic) declined to -$0.81 in Q2 2026 per NRIX's latest filing, from -$0.8 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.45 in Q2 2023 and bottomed at -$1.03 in Q3 2025.
- Historically, EPS (Basic) has averaged -$0.79 across 5 years, with a median of -$0.79 in 2023.
- Annual changes were most pronounced in 2022 — EPS (Basic) sank 68.14% — and 2023, when it soared 55.75%.
- Nurix Therapeutics' EPS (Basic) stood at -$0.96 in 2022, then grew by 19.66% to -$0.77 in 2023, then slipped by 12.97% to -$0.87 in 2024, then decreased by 3.47% to -$0.9 in 2025, then climbed by 10.7% to -$0.81 in 2026.
- Business Quant data shows NRIX's EPS (Basic) at -$0.81 in Q2 2026, -$0.8 in Q1 2026, and -$0.9 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Nurix Therapeutics | 2.86 Bn | 2.41 Bn | - | -0.81 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.81 |
| Feb 28, 2026 | -0.79 |
| Nov 30, 2025 | -0.90 |
| Aug 31, 2025 | -1.03 |
| May 31, 2025 | -0.52 |
| Feb 28, 2025 | -0.67 |
| Nov 30, 2024 | -0.87 |
| Aug 31, 2024 | -0.67 |
| May 31, 2024 | -0.71 |
| Feb 29, 2024 | -0.76 |
| Nov 30, 2023 | -0.77 |
| Aug 31, 2023 | -0.68 |
| May 31, 2023 | -0.45 |
| Feb 28, 2023 | -0.75 |
| Nov 30, 2022 | -0.96 |
| Aug 31, 2022 | -0.90 |
| May 31, 2022 | -1.01 |
| Feb 28, 2022 | -0.95 |
| Nov 30, 2021 | -0.88 |
| Aug 31, 2021 | -0.65 |